Replies to post #25833 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Dr. Isa Odidi, CEO and Co-Chief Scientist of the Company, stated, "Contesting litigation of this nature is part of what it takes to compete for the right to market valuable novel drug products in the United States. We have engaged highly regarded patent counsel with substantial directly applicable experience. We believe that we do not infringe the subject patents and that we have a well-prepared strategy to vigorously defend the Company against these claims."

[doogdilinger]

It's actually a great thing that Purdue finally filed suit as now IPCI's path to commercialization was just made a lot clearer and like Collegium, IPCI will easily prevail and can now get serious about selecting a partner:)